Immuneel Raises ₹100 Crore Series B For Cancer Therapies
Why Has Immuneel Therapeutics Raised Fresh Capital? Cancer-focused biotechnology startup Immuneel Therapeutics has secured more than ₹100 crore ($10.5 million) in a Series B funding round as it looks to accelerate the commercialization of advanced cancer therapies and expand its international footprint. The funding round attracted participation from a combination of new and existing investors, […]